Islet Cell Transplant Ditches Need for Immunosuppression
By Anette Breindl
Thursday, October 31, 2013
Scientists have developed a method to shield transplanted cells from the transplant recipient’s immune system, enabling them to transplant a diabetic patient with insulin-producing islet cells that remained invisible to his immune system. For now, the system is too complex for widespread use. “There [are] technical problems that need to be addressed to make this accessible to a regular patient,” noted co-author Stefan Bornstein. But “for almost a year, these human islets survived without any immunosuppression” – the first report of a transplant that has not necessitated immunosuppressive treatment for the patient.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.